Valuation (7%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -16.76 | -19.34 |
PEG Ratio (TTM) | -0.57 | -6.10 |
P/S Ratio (TTM) | N/A | 45.38 |
P/B Ratio (TTM) | 9.36 | 29.05 |
P/FCF Ratio (TTM) | -1.10 | -3.91 |
Price to 5YR AVG Earnings Ratio | -10.58 | -6.78 |
Price to 5YR AVG FCF Ratio | -0.93 | -12.87 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -33.55% | -15.27% |
ROE (TTM) | -48.95% | 26.93% |
Net Profit Margin (TTM) | N/A | -648.73% |
ROIC 5YR AVG | -40.06% | -8.24% |
Growth (10%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -25.50% | 28.46% | -2.93% |
Revenue | N/A | N/A | N/A |
Net Income | -2.80% | -29.92% | -21.53% |
Cash Flow | 1.19% | -32.10% | -19.16% |
Health (7%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.40 | 5.58 |
Quick Ratio (TTM) | 0.17 | 5.36 |
D/E Ratio (TTM) | N/A | 0.98 |
Interest Coverage (TTM) | N/A | -6.85 |
Piotroski F-Score | 3 | 5 |
Altman Z-Score | N/A | 12.49 |
LTL to 5YR AVG FCF | 0.00 | 0.08 |
Shares Outstanding Growth 5YR AVG | 41.22% | 37.38% |